Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04364113Phase 3Completed
Phase 3, randomised, open-label trial in chronic kidney disease (CKD) (8 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Change in GFR slope at 4 years. Started Jan 1989; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04364113.